# Octapharma S.A.S. – FDA Inspection, Sep 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-sas/54fce8f8-3b37-474d-8985-df0f1f8c15e3
Source feed: FDA_Inspections

> FDA inspection 1337368 of Octapharma S.A.S., September 25, 2026. 5 citations under 21 CFR parts 211 and 600. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1337368
- Company Name: Octapharma S.A.S.
- Inspection Date: 2026-09-25
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 5

## Related Documents

- [FDA Inspection 1297752 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/octapharma-sas/50d5a481-2788-48a4-8cd3-b0373bafd8a6)
- FDA Inspection 1192276 - 2022-12-06
- [FDA Inspection 1092062 - 2019-04-08](https://www.keypedia.com/records/fda_inspections/octapharma-sas/8336c1b4-15a5-4df3-94ea-1d6fe1373690)
- [FDA Inspection 1053918 - 2018-05-25](https://www.keypedia.com/records/fda_inspections/octapharma-sas/7bd08da8-7c54-4729-8d20-ef89bd48c8a4)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/olga-simakova/89ab2639-00a3-4dc1-9f97-5d17a43e9a66)
- [Company Rep](https://www.keypedia.com/people/priscilla-m-pastrana/170080d1-49da-42d7-8615-c774cac9f7ec)

Company: https://www.keypedia.com/companies/octapharma-sas/8e602de5-b511-4b74-aa10-2b4d1ef83dd5

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8